Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE

FDA approves GSK's Nucala for use in adults with chronic rhinosinusitis with nasal polyps - PharmaLive

Mepolizumab as Anti-interleukin-5 Therapy for Chronic Rhinosinusitis with Nasal Polyposis - touchRESPIRATORY

Comorbidity Data NUCALA (mepolizumab) for HCPs

PDF) Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study

Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count - ScienceDirect

Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study

Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis - ScienceDirect

Hobson ENT - I am exceedingly proud to have been involved in this multicentre, phase 3 RCT on Mepolizumab which is a new class of biological agent used of the treatment of

JPM, Free Full-Text